Search research articles
Contact Us
Filters
Showing results (21-30 of 29) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 29 results.
The Journal of Experimental Medicine
|
June 23, 2010
ATM-deficient thymic lymphoma is associated with aberrant tcrd rearrangement and gene amplification
Shan Zha, Craig H Bassing, Takaomi Sanda, et al.
Journal of Virology
|
May 24, 2013
Recombinant IgA is sufficient to prevent influenza virus transmission in guinea pigs
Christopher W Seibert, Saad Rahmat, Jens C Krause, et al.
Journal for Immunotherapy of Cancer
|
October 14, 2024
Intratumoral STING agonist reverses immune evasion in PD-(L)1-refractory Merkel cell carcinoma: mechanistic insights from detailed biomarker analyses
Thomas Pulliam, Saumya Jani, Peter H Goff, et al.
Journal of Virology
|
July 21, 2017
Synthetic Toll-Like Receptor 4 (TLR4) and TLR7 Ligands Work Additively via MyD88 To Induce Protective Antiviral Immunity in Mice
Peter H Goff, Tomoko Hayashi, Wenqian He, et al.
Molecular Pharmaceutics
|
June 4, 2020
Combined Intranasal Nanoemulsion and RIG-I Activating RNA Adjuvants Enhance Mucosal, Humoral, and Cellular Immunity to Influenza Virus
Pamela T Wong, Peter H Goff, Rachel J Sun, et al.
Advances in Radiation Oncology
|
August 25, 2020
Postoperative, Single-Fraction Radiation Therapy in Merkel Cell Carcinoma of the Head and Neck
Maclean M Cook, Stephanie K Schaub, Peter H Goff, et al.
Journal of the American Academy of Dermatology
|
October 1, 2023
Increased risk of recurrence and disease-specific death following delayed postoperative radiation for Merkel cell carcinoma
Nora A Alexander, Stephanie K Schaub, Peter H Goff, et al.
Journal of Virology
|
January 9, 2015
Synthetic Toll-like receptor 4 (TLR4) and TLR7 ligands as influenza virus vaccine adjuvants induce rapid, sustained, and broadly protective responses
Peter H Goff, Tomoko Hayashi, Luis Martínez-Gil, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 4, 2022
Neoadjuvant Therapy Induces a Potent Immune Response to Sarcoma, Dominated by Myeloid and B Cells
Peter H Goff, Laura Riolobos, Bonnie J LaFleur, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 29) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 29 results.
The Journal of Experimental Medicine
|
June 23, 2010
ATM-deficient thymic lymphoma is associated with aberrant tcrd rearrangement and gene amplification
Shan Zha, Craig H Bassing, Takaomi Sanda, et al.
Journal of Virology
|
May 24, 2013
Recombinant IgA is sufficient to prevent influenza virus transmission in guinea pigs
Christopher W Seibert, Saad Rahmat, Jens C Krause, et al.
Journal for Immunotherapy of Cancer
|
October 14, 2024
Intratumoral STING agonist reverses immune evasion in PD-(L)1-refractory Merkel cell carcinoma: mechanistic insights from detailed biomarker analyses
Thomas Pulliam, Saumya Jani, Peter H Goff, et al.
Journal of Virology
|
July 21, 2017
Synthetic Toll-Like Receptor 4 (TLR4) and TLR7 Ligands Work Additively via MyD88 To Induce Protective Antiviral Immunity in Mice
Peter H Goff, Tomoko Hayashi, Wenqian He, et al.
Molecular Pharmaceutics
|
June 4, 2020
Combined Intranasal Nanoemulsion and RIG-I Activating RNA Adjuvants Enhance Mucosal, Humoral, and Cellular Immunity to Influenza Virus
Pamela T Wong, Peter H Goff, Rachel J Sun, et al.
Advances in Radiation Oncology
|
August 25, 2020
Postoperative, Single-Fraction Radiation Therapy in Merkel Cell Carcinoma of the Head and Neck
Maclean M Cook, Stephanie K Schaub, Peter H Goff, et al.
Journal of the American Academy of Dermatology
|
October 1, 2023
Increased risk of recurrence and disease-specific death following delayed postoperative radiation for Merkel cell carcinoma
Nora A Alexander, Stephanie K Schaub, Peter H Goff, et al.
Journal of Virology
|
January 9, 2015
Synthetic Toll-like receptor 4 (TLR4) and TLR7 ligands as influenza virus vaccine adjuvants induce rapid, sustained, and broadly protective responses
Peter H Goff, Tomoko Hayashi, Luis Martínez-Gil, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 4, 2022
Neoadjuvant Therapy Induces a Potent Immune Response to Sarcoma, Dominated by Myeloid and B Cells
Peter H Goff, Laura Riolobos, Bonnie J LaFleur, et al.
Page
of 3